Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Led by a ‘give first’ ethos, Techstars becomes a B-Corp
When your company mantra is “give first,” it’s bound have a philanthropic focus. And that ideology seems to have driven Techstars’ recent move to become a certified “B Corporation,” entailing the investment and accelerator group adhere to strict standards of social and environmental performance, accountability and transparency. A “B Corp” — or benefit corporation —…
Venture for America launches in KC to help startups find talent
A national fellowship program that helps recent graduates launch careers in entrepreneurship announced an expansion into Kansas City. With a mission to revitalize American cities, Venture for America partners with startups, business leaders and foundations to connect young talent with early-stage companies. In addition to the opportunity to work hands on with startups, The New…
Events Preview: Digital inclusion, term sheets
There are a plethora of entrepreneurial events hosted in Kansas City on a weekly basis. Whether you’re an entrepreneur, investor, supporter, or curious community member — we recommend these upcoming events for you. Weekly Events Preview Smart Companies to Watch When: Dec. 7, 5:30 p.m. – 7:30 p.m. Where: The Downtown Marriott Thinking Bigger is…
Smart road startup Integrated Roadways launching IoT test lab with MoDOT
The Missouri Department of Transportation is looking to Kansas City-based Integrated Roadways for its tech and Internet of Things insight. As part of a 15-year agreement, the firm will serve as the department’s “IoT broker” and will build and operate a testing lab that will enable Missouri to explore the top mobile-Internet innovations, Integrated Roadways…